Neurotoxicity and cognitive outcomes in modern therapies for primary central nervous system lymphoma

Angel Escamilla-Ramírez, Caroline Houillier, Khê Hoang-Xuan

Open source

DOI
10.1097/cco.0000000000001269
Published
2026-09-18
Container
Current Opinion in Oncology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/cco.0000000000001269,
  title = {Neurotoxicity and cognitive outcomes in modern therapies for primary central nervous system lymphoma},
  author = {Angel Escamilla-Ramírez and Caroline Houillier and Khê Hoang-Xuan},
  year = {2026},
  journal = {Current Opinion in Oncology},
  doi = {10.1097/cco.0000000000001269},
  url = {https://doi.org/10.1097/cco.0000000000001269}
}

RIS

TY  - JOUR
TI  - Neurotoxicity and cognitive outcomes in modern therapies for primary central nervous system lymphoma
AU  - Angel Escamilla-Ramírez
AU  - Caroline Houillier
AU  - Khê Hoang-Xuan
PY  - 2026
JO  - Current Opinion in Oncology
DO  - 10.1097/cco.0000000000001269
UR  - https://doi.org/10.1097/cco.0000000000001269
ER  - 

APA

Escamilla-Ramírez, A., Houillier, C., & Hoang-Xuan, K. (2026). Neurotoxicity and cognitive outcomes in modern therapies for primary central nervous system lymphoma. Current Opinion in Oncology. https://doi.org/10.1097/cco.0000000000001269

Source records